Clinical Trial Update: A Study Assessing Patient Handling of Flutiform® Breath-Actuated Inhaler (BAI) and Flutiform® Pressurised Metered Dose Inhaler (pMDI)

View source ↗

Summary

This clinical trial update notes the completion of a study evaluating how patients handle Flutiform inhalers (breath-actuated and pressurized MDI) in asthma and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• FlutiForm (fluticasone propionate/formoterol)

Snippet

Sponsor: Mundipharma Research Limited | Conditions: Asthma, COPD | Status: COMPLETED